These Next-Generation Cholesterol Drugs Could Raise U.S. Healthcare Costs by $119 Billion a Year

These Next-Generation Cholesterol Drugs Could Raise U.S. Healthcare Costs by $119 Billion a Year

Submitted by admin on August 28, 2016 - 10:07am
Source: 
Motley Fool
News Tags: 
PCSK9 inhibitors
Amgen
Repatha
Regeneron
Praluent
Sanofi
Headline: 
These Next-Generation Cholesterol Drugs Could Raise U.S. Healthcare Costs by $119 Billion a Year

Do Not Allow Advertisers to Use My Personal information